Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Healthcare Biotechnology
Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Lattice Biologics Ltd > 18 million shares and 500,000 warrants at 10 cents
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(19)
•••
Comment by Smiles62on Jul 24, 2020 7:13am
85 Views
Post# 31312703

RE:RE:RE:RE:RE:RE:RE:18 million shares and 500,000 warrants at 10 cents

RE:RE:RE:RE:RE:RE:RE:18 million shares and 500,000 warrants at 10 cents

I'm not basing your "God" Guy but in my mind (I could be wrong), why did he negotiate such a fatal deal with her, I'm just wandering who is the smarter of the 2?
Why could he not negotiate at half the number of shares?  Then he would have fought for his sh. In other words 9M instead of 18M, the amount to her would have been the same $1M, but the new overhang for us would have been less painful, 2 fold, the number and the price, which would have been 100% of what it is now?  0.10 instead of 0.05.  Or meet half ways, at 0.075. (50% higher for us)?
If I read the NR correctly, the litigation is not even settled, why put out such a negative NR?  You should just put out a NR stating the settlement.  Right now it leaves a message of she actually controls everyone's faith, she could accept or refuse, renegociate.
It also leaves a message that this is not just a business dispute!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities